Please assess the completion status of the following clinical trial:

Trial Title: Wound Protector Dual-ring Alexis® in Pancreaticoduodenectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Scheduled for elective PD~* Age ≥ 18 years~* Ability of the subject to understand character and individual consequences of the clinical trial~* Written informed consent~Exclusion Criteria:~* Under 18 years of age~* Unable to sign informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Alexis® device (Type: EXPERIMENTAL): In this group, we will be used WP dual-ring Alexis® (Figure 1). The Alexis® 's size will be decided on the basis of abdominal incision (Alexis® X-Large or Alexis® XX-Large will be used for 11-17cm or 17-25 cm incision length respectively)
- Standard 3M™ Steri-Drape 2 (Type: ACTIVE_COMPARATOR): In this group, we will be used Standard 3M™ Steri-Drape 2

Based on this trial design, predict the completion outcome and termination type (if applicable).